Robuta

https://www.glycomine.com/ Replacement Therapies for Rare Diseases| PMM2-CDG | Glycomine Apr 2, 2026 - We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment. rare diseases pmm2 cdg replacement therapies